Salivary Markers in Patients with Chronic Renal Failure
Overview
Authors
Affiliations
Introduction: Chronic renal failure (CRF) is a progressive loss of renal function over a period of months or years. The major function of the kidneys is the removal of metabolic waste products, electrolytes and water. When this function is impaired, systemic changes, oral complications and alterations in salivary composition may occur.
Objective: This study aimed to compare the levels of immunological and inflammatory components in the saliva samples from patients that undergo to hemodialysis treatment (HD), without HD and control.
Design: This study evaluated IgA, IgG, C reactive protein (CRP) and nitric oxide (NO) in saliva samples from 119 patients, who were divided into the control group (C), chronic renal failure (CRF) patient group and CRF patients on hemodialysis treatment (HD) group. IgA and IgG levels were analyzed by ELISA. Nitric oxide levels were determined indirectly by the nitrite concentration using Griess reagent; CRP by agglutination tests; and total proteins, by Bradford assay.
Results: The HD group showed significantly higher levels of IgG, IgA and CRP compared with the control and CRF groups. The CRF group presented the same amounts of IgG, IgA and CRP as the C group but significantly higher levels of NO similar to the HD group.
Conclusion: Renal disease, particularly hemodialysis treatment during renal disease, seems to alter salivary immunological and inflammatory components. Thus, analyzing the levels of IgA, IgG, NO and CRP in saliva may be beneficial for monitoring renal disease.
Picolo B, Silva N, Martins M, Almeida-Souza H, de Sousa L, Polveiro R Front Med (Lausanne). 2025; 11:1302637.
PMID: 39895822 PMC: 11784343. DOI: 10.3389/fmed.2024.1302637.
Deng W, Liu C, Cheng Q, Yang J, Chen W, Huang Y Int Urol Nephrol. 2024; 56(7):2391-2402.
PMID: 38436825 DOI: 10.1007/s11255-024-03953-6.
The Role of Salivary C-Reactive Protein in Systemic and Oral Disorders: A Systematic Review.
Babaei M, Rezaei S, Saghafi Khadem S, Shirinbak I, Basir Shabestari S Med J Islam Repub Iran. 2022; 36:138.
PMID: 36479533 PMC: 9719583. DOI: 10.47176/mjiri.36.138.
Tavares L, Saavedra-Silva M, Lopez-Marcos J, Veiga N, de Moraes Castilho R, Fernandes G Diseases. 2022; 10(1).
PMID: 35225864 PMC: 8883939. DOI: 10.3390/diseases10010012.
Lower p66Shc promoter methylation in subjects with chronic renal failure.
Hamdi R, Saadallah-Kallel A, Ferchichi-Trimeche S, Mokdad-Gargouri R, Miled A, Benarba B PLoS One. 2021; 16(9):e0257176.
PMID: 34529688 PMC: 8445414. DOI: 10.1371/journal.pone.0257176.